Katherine Van Loon, MD, MPH | Authors

Biomarkers in Colon Cancer: The Chasm Between Expectations and Reality

August 15, 2013

At this juncture, various commercially available assays for colon cancer may be of little added value, and accelerated biomarker development with clinical validation is desperately needed.

Metastatic Colorectal Cancer: A Curable Disease

March 13, 2012

Combined-modality therapy has rendered disease-free an increasing number of patients who were previously considered to be incurable. Still, despite myriad advances in imaging, and in surgical and therapeutic modalities, many patients who undergo resection of limited metastatic disease with curative intent ultimately relapse.